EW
Edwards Lifesciences Corp (EW)
Healthcare • NYSE • $79.96-3.38%
- Symbol
- EW
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $79.96
- Daily Change
- -3.38%
- Market Cap
- $46.04B
- Trailing P/E
- 43.22
- Forward P/E
- 23.78
- 52W High
- $87.89
- 52W Low
- $72.30
- Analyst Target
- $97.15
- Dividend Yield
- N/A
- Beta
- 0.87
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distr…
Company websiteResearch EW on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.